Live Breaking News & Updates on Director Laurence

Stay updated with breaking news from Director laurence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TG Therapeutics, Inc. Forecasted to Post FY2025 Earnings of $0.11 Per Share (NASDAQ:TGTX)

TG Therapeutics, Inc. Forecasted to Post FY2025 Earnings of $0.11 Per Share (NASDAQ:TGTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Laurencen Charney , Jpmorgan Chase Co , York State Common Retirement Fund , Kestra Advisory Services , Goldman Sachs Group , Valeo Financial Advisors , Tg Therapeutics Inc , Principal Financial Group Inc , Free Report , Get Free Report , Advisory Services , Financial Group , State Retirement System , Financial Advisors , Director Laurence ,

HC Wainwright Boosts TG Therapeutics (NASDAQ:TGTX) Price Target to $49.00

TG Therapeutics (NASDAQ:TGTX – Free Report) had its price objective increased by HC Wainwright from $45.00 to $49.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other analysts have also recently issued reports on the stock. The Goldman Sachs […] ....

Los Angeles , United States , Laurencen Charney , Tg Therapeutics Company Profile , Goldman Sachs Group , Principal Financial Group Inc , Wealth Effects , Los Angeles Capital Management , Hennion Walsh Asset Management Inc , Jpmorgan Chase Co , Raymond James Financial Services Advisors Inc , Tg Therapeutics Inc , Free Report , Moderate Buy , Trading Down , Get Free Report , Director Laurence , Financial Group , James Financial Services Advisors , Walsh Asset Management , Angeles Capital Management , Tg Therapeutics , Nasdaq Tgtx , Boost Price Target , Hc Wainwright ,

HC Wainwright Raises TG Therapeutics (NASDAQ:TGTX) Price Target to $49.00

HC Wainwright Raises TG Therapeutics (NASDAQ:TGTX) Price Target to $49.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Laurencen Charney , Investment Management , Securities Inc , Financial Services Group Inc , Goldman Sachs Group , Tg Therapeutics Inc , Pingora Partners , Jpmorgan Chase Co , Get Free Report , Director Laurence , Services Group ,

TG Therapeutics (NASDAQ:TGTX) PT Raised to $49.00 at HC Wainwright

TG Therapeutics (NASDAQ:TGTX – Get Free Report) had its price target boosted by research analysts at HC Wainwright from $45.00 to $49.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 202.66% from the company’s […] ....

United States , Laurencen Charney , Pingora Partners , Tg Therapeutics Inc , Jpmorgan Chase Co , Securities Inc , Investment Management , Financial Services Group Inc , Goldman Sachs Group , Get Free Report , Director Laurence , Services Group ,